FRI-321 - A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study

Autor: Wranke, A., Yurdaydin, C., Heidrich, B., Kalliopi, Z., Yalcin, K., Fehmi, T., Akarca, U., Lammert, F., Häussinger, D., Müller, T., Wöbse, M., Manns, M.P., Wedemeyer, H., Hardtke, S.
Zdroj: In Journal of Hepatology April 2018 68 Supplement 1:S507-S507
Databáze: ScienceDirect
Externí odkaz: